Neuroscience Market
The neuroscience market comprises products that are
used for various applications in the field of neuroscience research including
proteomics, genomics, connectomics, neuroinformatics, neuroimaging,
transcriptomics, electrophysiology, and drug development. Neuroscience products
find applications in studying nervous system development and function, mapping
the human connectome, neurodegenerative diseases, neurovascular diseases, and
other neurological disorders.
The
global Neuroscience Market is
estimated to be valued at US$37.73
Billion in 2024 and is expected to exhibit a CAGR Of 21% over the forecast period 2024-2031, as highlighted in a new report published by Coherent
Market Insights.
Market Opportunity:
The opportunity for personalized medicine in neuroscience is driving the high
growth of the market. Neuroscience research provides insights into the
underlying causes of neurological disorders at molecular and cellular level.
This research has the potential to enable personalized treatment approaches for
neurological disorders. For example, genomic and proteomic analysis can help
understand individual susceptibility and response to particular treatments.
Neuroimaging and brain mapping can help develop personalized rehabilitation and
treatment plans. Advancements in fields like connectomics, neuroinformatics and
systems neuroscience are bringing the possibility of personalized medicine in
neuroscience a step closer. Personalized treatment approaches promise more
effective outcomes for various conditions like Alzheimer's, Parkinson's,
epilepsy and brain injuries. This presents a major market opportunity for
neuroscience products and research in the coming years.
Porter's Analysis
Threat of new entrants: The neuroscience market requires extensive research and
development capabilities as well as significant capital investments which make
it difficult for new players to enter the market.
Bargaining power of buyers: Individual buyers have low bargaining power in the
neuroscience market as it provide specialized products and services. However,
large pharmaceutical companies may have some bargaining power.
Bargaging
power of suppliers: A few key scientific instrument and technology providers
dominate the supply market, giving them significant bargaining power over
buyers.
Threat
of new substitutes: There are limited substitute available for neuroscience
research tools, assay and services. New alternative therapies may emerge as
potential substitutes.
Competitive
rivalry: The neuroscience market is highly competitive due intensive R&D
activities and presence of numerous global and local players. Key players
competitively differentiate their products and services to gain market share.
SWOT Analysis
Strengths: Growing prevalence of neurological disorders, increasing R&D
investments and advancing neuroimaging and molecular techniques.
Weaknesses:
High costs associated with neuroscience research, lack of skilled workforce and
ambiguous regulations.
Opportunities:
Emerging economies, expanding application areas in drug discovery, growing
focus on personalized neurotherapeutics.
Threats:
Ethical issues related to brain research, stringent regulatory approvals and
data privacy concerns.
Key Takeaways
The
Global Neuroscience Market Demand is
expected to witness high growth over the forecast period owing to increasing
incidence of neurological disorders, expanding application areas and
significant investments in R&D.
North
America dominates the global neuroscience market led by the US driven by
presence of major players, higher healthcare spending and growing neurological
disorders. Europe is the second largest market led by Germany, UK and France.
Key
players operating in the neuroscience market are Agilent Technologies Inc., F.
Hoffmann-La Roche Ltd, Nucleome Informatics Private Limited, Azenta Life
Sciences, Bio-Rad Laboratories Inc., Danaher Corporation, Douglas Scientific
LLC, AllGenetics & Biology SL, Illumina Inc., Life Technologies Corp.,
Consultative Group on International Agricultural Research, Avance Biosciences,
Genotypic Technology Pvt Ltd, Xelect Ltd, Taconic Biosciences, Inc., Luminex
Corp., Promega Corporation, CD Genomics, Synbio Technologies, Thermo Fischer
Scientific Inc., Sequenom, PREMIER Biosoft, Fluidigm Corporation, Novacyt,
Twist Bioscience, Regeneron Pharmaceuticals, Inc, NRGene, and LGC Biosearch
Technologies, among other prominent players.
Get
more insights on this topic :
https://www.marketwebjournal.com/the-neuroscience-market-is-expected-to-be-flourished-by-growing-adoption-of-neuroscience-research/
Comments
Post a Comment